These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34966384)

  • 1. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
    Front Immunol; 2021; 12():760683. PubMed ID: 34966384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
    Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
    Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
    Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
    Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
    Kang MQ; Cao YP; Deng F
    Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease.
    Ekeke CN; Russell KL; Murthy P; Guo ZS; Soloff AC; Weber D; Pan W; Lotze MT; Dhupar R
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):e313-e328. PubMed ID: 33485667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity.
    Fan Y; Chen A; Zhu J; Liu R; Mei Y; Li L; Sha X; Wang X; Ren W; Wang L; Liu B
    Cancer Lett; 2024 Apr; 588():216777. PubMed ID: 38432582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
    Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
    Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutical effects of pleural injecting recombinant human endostain to 
malignant pleural effusion nude mice model].
    Zhou M; Li M; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
    Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
    Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
    Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J
    Front Immunol; 2018; 9():2916. PubMed ID: 30619280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
    Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
    Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG
    Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma.
    Matsumoto S; Tanaka F; Sato K; Kimura S; Maekawa T; Hasegawa S; Wada H
    Lung Cancer; 2009 Oct; 66(1):75-9. PubMed ID: 19178977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
    Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
    J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sulindac analogue is effective against malignant pleural effusion in mice.
    Moschos C; Psallidas I; Cottin T; Kollintza A; Papiris S; Roussos C; Stathopoulos GT; Giannis A; Kalomenidis I
    Lung Cancer; 2011 Aug; 73(2):171-5. PubMed ID: 21227533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.
    Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K
    Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
    Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
    Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.